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Summary 
Malaria during pregnancy is a major factor in infant morbidity and mortality. In this issue 
of Cell Host and Microbe Conroy et al (2013) propose that C5a, a product of complement 
cascade activation, counteracts the placental vascular remodeling response induced by 
Plasmodium infection and contributes to fetal growth restriction. 
 
In Māori tradition the placenta (whenua in Māori language) is buried upon birth to 
establish a link between the land (likewise called whenua) and the newborn. Both types 
of whenua nourish: “one allows the foetus to become a baby with all the potential to 
become a strong and healthy adult and the other sees that person develop and grow, make 
their contribution to society and then be “born” into the spirit of the world” (Head and 
Head, 2003). Although the placenta is credited with the developing fetus, surprisingly 
little is known about critical molecules and physiological parameters that control the 
functional efficacy of this fast-growing organ and determine pregnancy success.  
 
Fetal growth restriction is a severe consequence of malarial disease during pregnancy and 
thought to result largely from placental insufficiency. Much research has been centered 
on the pathogenic role of ligand-receptor interactions between the Plasmodium-infected 
erythrocyte and placental tissues (reviewed by Duffy and Fried, 2005). Parasite antigens 
expressed on the surface of infected erythrocytes are thought to contribute to 
accumulation of parasitized cells in the placenta. The best example is var2csa, member 
of the var (variable surface antigen) gene family which is selectively expressed by 
infected erythrocytes that accumulate in the placenta (Salanti et al., 2003). VAR2CSA 
has strong affinity to the glycosaminoglycan chondrotin sulphate A (CSA or C4S) present 
in high amounts in the intervillous space and on the surface of syncytiotrophoblasts which 
contact the maternal blood. The current pathogenesis model is focused on linking 
placental sequestration of infected erythrocytes to a series of inflammatory events that 
can reduce fetal growth. Cytoadhesion of infected erythrocytes can activate 
syncytiotrophoblast cell secretion of chemokines which attract maternal inflammatory 
cells (Lucchi et al., 2008). But how does inflammation impair maternal-fetal exchange? 
Little attention has been paid to the impact of malaria physiology in the fast-developing 
placenta that in the course of malaria infection may contribute to placental insufficiency. 
Recently the pathogenesis paradigm was challenged by work that addresses the role of 
angiogenesis factors (reviewed by Conroy et al., 2011), the coagulation cascade (Avery 
et al., 2012) and placental microcirculation (Moraes et al., 2013). 
 
In this issue, Conroy et al. investigate potential links between inflammation, angiogenesis 
alterations and fetal growth restriction in pregnancy-associated malaria. They focus on 
activation of the complement cascade previously shown to impair placental vascular 
remodeling in mouse models of miscarriage or fetal growth restriction (reviewed by 
Girardi, 2008). Complement cascade activation by immune complexes in the placenta 
may indirectly contribute to inflammation. C5a – a protein fragment released by the 
activation of C5 complement component – was shown to be implicated in tissue injury 
by inducing release of reactive oxygen species of C5a-activated neutrophils. 
Nevertheless, in antibody-independent models of unsuccessful pregnancy, inflammatory 
cells indirectly generate C5a fractions that activate monocytes to produce soluble vascular 
endothelial growth factor (sVEGF), an inhibitor of VEGF. This deregulation of 
angiogenic factors is hypothesized to disturb the developing placental vascularization and 
as a consequence impeding babies of getting appropriate nurturing.  
 
The study by Conroy et al (2013) tackles this issue and provides epidemiological data 
and compelling experimental evidence that placental vascular insufficiency is a cause of 
low birth weight in placental malaria and is partially mediated by C5a. The authors 
observe that elevated C5a levels in women infected with Plasmodium falciparum during 
pregnancy are associated with low weight babies and altered levels of angiogenic factors. 
This causative chain is demonstrated using C5a receptor (C5aR) deficient mice, where P. 
berghei infection during pregnancy resulted in decreased placental arterial vascular 
resistance and correlated with improved fetal viability and birth weight. Impressively, this 
was verified by 3D micro-CT placental scanning, allowing the visualization of 
significantly increased vascular branching in the absence of C5a. Usage of C5a deficient 
mice was key to distinguish the placental pro-angiogenic response to malaria infection, 
from the anti-angiogenic response resulting from C5a activity. High levels of C5a elicited 
by the malaria infection tilt the balance of these two concurrent responses, presumably 
impairing development of the feto-placental arterial vasculature and leading to increased 
arterial resistance.  
 
These observations imply that reduction of intraplacental blood circulation is harming 
fetal nurturing and suggest that reduced placental perfusion elicited by other mechanisms 
involved in the response to infection may also contribute to fetal growth restriction. Using 
different mouse and parasite strains we have observed decreased placental vascularization 
and reduction of the maternal blood space in the labyrinth region of Plasmodium-infected 
placentas (Rodrigues-Duarte et al., 2012). Maternal blood microcirculation in the mouse 
placenta was recently shown to promote sequestration of P. berghei-infected erythrocytes 
in maternal blood spaces with reduced or no flow (Moraes et al., 2013). The C5a effect 
on angiogenesis could aggravate maternal blood perfusion in infected placentas, favoring 
parasite sequestration, amplifying the placental response mechanisms and impoverishing 
te whenua (Figure 1). Excessive fibrin deposition in the infected placenta has been 
associated with a dramatic upregulation of tissue factor (TF) resulting in a procoagulant 
and antifibrinolytic response (Avery et al., 2012). These authors claim that therapeutically 
targeting hemostasis deregulation improved placental pathology and ameliorated 
pregnancy outcomes. Remarkably, as shown by Conroy et al. (2013), antibody inhibition 
of C5a-C5aR signaling improved fetal weight of infected pregnant mice. This highlights 
the C5a-C5aR signaling axis as a target of therapeutics that may enable restoration of 
placental sufficiency to protect fetal growth and viability in the presence of malaria 
infection. Focusing the research on placental insufficiency is conveying the notion that 
poor pregnancy outcomes of malaria infection might be mitigated by therapeutically 
restoring placental functional efficacy independent of anti-parasite therapies. 
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 Figure legend 
Plasmodium infection and placenta mal-function. Accumulation of infected erythrocytes 
in maternal blood spaces leads to inflammatory mononuclear cell recruitment. In this 
inflammatory mellieu generation of C5a pro-inflammatory activity contributes to 
imbalance of angiogenic factors. As a result of this anti-angiogenic response, 
intraplacental vascular resistance increases impairing placental perfusion. Altered 
hemodynamics in the infected placenta conditions maternal blood flow which promotes 
infected erythrocyte accumulation. This cycle amplifies the inflammatory response 
leading to placental dysfunction and impacting fetal growth. Therapeutic intervention 
aiming to decrease C5a generation/signaling could contribute to promote a pro-
angiogenic response and restore placental perfusion counteracting the deleterious effects 
of placental malaria in the pregnancy outcome. 
 
 
